Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00256360
Status:
COMPLETED
Last Update Posted:
2014-12-09
First Post:
2005-11-16
Brief Title:
Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil Epirubicin Plus Cyclophosphamide FEC and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Universitaire Ziekenhuizen KU Leuven
Organization Data
Organization:
Universitaire Ziekenhuizen KU Leuven
Class:
OTHER
Study ID:
2005-001876-11
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Lead Sponsor Class:
OTHER
Responsible Party:
prof dr Hans Wildiers
Responsible Party Title:
adjunct head of clinic
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Universitaire Ziekenhuizen KU Leuven
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| St-Augustinus Wilrijk | UNKNOWN |